Matched unrelated human umbilical cord blood transplantation for X- linked adrenoleukodystrophy Academic Article uri icon


  • Purpose: This report evaluates engraftment, immunologic reconstitution, and sera very-long-chain fatty acid levels after matched unrelated human umbilical cord blood transplantation (H[ICBT) for adrenoleukodystrophy (ALD). Patient and Methods: A child with X-linked ALD underwent matched unrelated HUCBT and administration of granulocyte colony stimulating factor in combination with erythropoietin. Results: Engraftment was complete and stable, with 100% chimerism. Natural killer cell numbers and function were normal more than 3 months after HUCBT. T cell numbers normalized more than 9 months after HUCBT but T cell mitogenic response remained subnormal. Thirteen months after transplantation, the child is in very good clinical condition with normalization of his sera very-long-chain fatty acid levels. Conclusion: Unrelated cord blood transplantation may provide a good source of stem cells for patients with ALD when a matched sibling is not available.

publication date

  • January 1, 1998